uk-plab-1 MCQ (SBA): Anaemia of chronic kidney disease and ESA use

Instant feedback + full explanation. One question, done properly.

ModerateHaematologyAnaemia of chronic kidney disease and ESA useuk-plab-1

A 70-year-old man with chronic kidney disease and normocytic anaemia is being considered for Erythropoiesis-stimulating agent (ESA) therapy. Which other treatment is usually required before or alongside ESA?

Educational content. Not a substitute for clinical judgement or local policy.

uk-plab-1 MCQ: Anaemia of chronic kidney disease and ESA use — Answer